April 2024: Volume 9, Issue 1
Medicare Advantage and Hospice Care: My Family’s Difficult Story
Neil S. Fleming, Hankamer School of Business, Baylor University
ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine
Robert Pearl, Stanford University School of Medicine, Stanford Graduate School of Business
A Business-Based Pathway to a Stronger U.S. Healthcare System
Richard M. Levy, Former Chairman and CEO, Varian
Current Common Procedural Terminology (CPT®) Coding Process Challenges: Impact on the HealthTech Innovation Ecosystem
Cheyenne Ariana Erika Modina, Sandra Waugh Ruggles, Juliana Perl, and Josh Makower, Stanford Byers Center for Biodesign, School of Medicine, Stanford University
Regi’s “Innovating in Healthcare” Cases
Pharmacy Benefit Managers and the U.S. Pharmaceutical Market
Rena M. Conti, Questrom School of Business, Boston University; Brigham Frandsen, Brigham Young University, and James B. Rebitzer, Questrom School of Business, Boston University
The Business of Health Care: AI, Elections, and the Economy
Karoline Mortensen, Steven G. Ullmann, and Richard Westlund, University of Miami Herbert Business School
Revitalizing Employee Network and Ensuring Workforce Stability
Angela Botiba, DivineMercy Bakare, and Erika Schlosser, Carlson School of Management, School of Public Health, Medical School, University of Minnesota.
What’s Exciting about Consumer Medical Price Transparency?
Stephen T. Parente, University of Minnesota, Carlson School of Management
A Review on the Role of Prior Authorization in Healthcare and Future Directions for Reform
Austin J. Allen and Markus Saba, UNC Kenan-Flagler Business School
Florida Wants to Import Low-Cost Prescription Drugs from Canada. Will Its Plan Work?
Paul Grootendorst, Leslie Dan Faculty of Pharmacy, University of Toronto